Boehringer Ingelheim Archives -

BI buys rights to NASH-targeted tech from Singapore’s Enleofen

https://pharmaphorum.com/news/bi-buys-rights-to-nash-targeted-tech-from-singapores-enleofen/

Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market

https://pharmaphorum.com/news/boehringer-gets-clearance-to-manufacture/

Boehringer, Lilly start acute heart failure trial with Jardiance

https://pharmaphorum.com/news/boehringer-lilly-start-acute-heart-failure-trial-with-jardiance/

Boehringer Ingelheim to present data at RAS Summit Europe

https://pharmaphorum.com/partner-content/boehringer-ingelheim-to-present-data-at-ras-summit-europe/

Lilly and Boehringer rejig diabetes alliance as Jardiance soars

https://pharmaphorum.com/news/lilly-and-boehringer-rejig-diabetes-alliance-as-jardiance-soars/

Which big pharma firms are best at digital?

https://pharmaphorum.com/views-analysis-digital/which-big-pharma-firms-are-best-at-digital/

FDA approves Bayer/Janssen’s Xarelto in new blood clot prevention use

https://pharmaphorum.com/news/fda-approves-bayer-janssens-xarelto-in-new-blood-clot-prevention-use/

BI signs KRAS deal with India’s Lupin, as pharma awaits key Amgen data

https://pharmaphorum.com/news/bi-signs-kras-deal-with-indias-lupin-as-pharma-awaits-key-amgen-data/

Boehringer jumps on KRAS cancer drug bandwagon with MD Anderson

https://pharmaphorum.com/news/boehringer-jumps-on-kras-cancer-drug-bandwagon-with-md-anderson/

Search